FDA and NIH Launch Joint Initiative to Transform Nutrition Research and Combat Chronic Disease

In a collaborative effort aimed at addressing the growing public health crisis of diet-related chronic diseases, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have announced the launch of the Nutrition Regulatory Science Program. This joint initiative is positioned as a key component of U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr.’s broader campaign to “Make America Healthy Again.” The program seeks to generate high-quality scientific evidence that will inform policy decisions to improve the nation’s diet and health outcomes.

The new program will pursue an ambitious research agenda designed to explore the underlying causes of diet-related illnesses. Areas of focus include investigating the health impacts of ultra-processed foods, assessing the effects of food additives on metabolic function, and studying how maternal and infant dietary patterns influence long-term health outcomes such as autoimmune disorders. By addressing these complex questions, the FDA and NIH aim to develop regulatory strategies grounded in scientific rigor.

Building on the model of the FDA-NIH Tobacco Regulatory Science Program, this initiative will leverage the FDA’s regulatory science capabilities alongside NIH’s robust research infrastructure. The collaboration will bring together multidisciplinary experts in fields ranging from toxicology and behavioral science to chemistry and nutrition. The goal is to support science-based policymaking and enhance transparency about food-related health risks.

The agencies emphasized that all research conducted under the Nutrition Regulatory Science Program will be held to high standards of fairness and independence, with safeguards in place to prevent conflicts of interest. The partnership reflects a unified commitment to transforming the national approach to food and health policy through coordinated federal action.

Article by multiple RFHC contributors, based upon information from a joint FDA and NIH press release.

---